Innoviva
INVA
#5594
Rank
A$2.11 B
Marketcap
A$29.29
Share price
0.15%
Change (1 day)
-2.90%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2026 (TTM): A$0.88 Billion

According to Innoviva's latest financial reports the company's current earnings are A$0.42 Billion. In 2025 the company made an earning of A$0.46 Billion, an increase over its 2024 earnings that were of A$52.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.88 B92.19%
2025 A$0.46 B774.24%
2024 A$52.87 M-80.74%
2023 A$0.27 B-32.36%
2022 A$0.40 B-35.56%
2021 A$0.62 B25.7%
2020 A$0.50 B52.11%
2019 A$0.32 B10.77%
2018 A$0.29 B56.59%
2017 A$0.18 B125.53%
2016 A$84.2 M-417.36%
2015 -A$26.54 Million-74.49%
2014 -A$0.11 Billion-25.19%
2013 -A$0.14 Billion430.06%
2012 -A$26.23 Million-83.92%
2011 -A$0.17 Billion39.82%
2010 -A$0.12 Billion2.84%
2009 -A$0.12 Billion-8.62%
2008 -A$0.13 Billion-47.92%
2007 -A$0.24 Billion-5.92%
2006 -A$0.26 Billion19.8%
2005 -A$0.22 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.33 Billion-138.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$25.68 Million-103.03%๐Ÿ‡บ๐Ÿ‡ธ USA